PUBLIC COMPANY
saveBristol-Myers Squibb Co
updated 2mo ago
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of multip read more
…
community read0 votes
🐶 often sniffed alongside
top 8- drugOPDIVO12 co-mentions · 6 sources
- drugOPDIVO QVANTIG12 co-mentions · 6 sources
- drugnivolumab12 co-mentions · 6 sources
- tagApproval10 co-mentions · 5 sources
- tagOncology9 co-mentions · 1 sources
- drug(hyaluronidase (recombinant, human) + nivolumab)5 co-mentions · 5 sources
- tagNSCLC2 co-mentions · 1 sources
- tagGlioblastoma2 co-mentions · 1 sources
pipeline
47
marketed
20
phase 3
8
catalysts ytd
4
approvals ytd
3
recalls ytd
0
Pipeline(47)
view full pipeline →pipeline depth47 products
5Phase 113Phase 28Phase 320Marketed1pre_registration
Marketed
(atazanavir sulfate + cobicistat)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketed(hyaluronidase (recombinant, human) + nivolumab)
Adenocarcinoma Of The Gastroesophageal Junction
Marketed(nivolumab + relatlimab)
Metastatic Melanoma
Marketed(trospium chloride + xanomeline tartrate)
Psychosis
MarketedAzactam
Abscess
MarketedLENALIDOMIDE
Follicular Lymphoma
CRL4(CRBN) E3 ubiquitin ligase
MarketedOnureg
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
MarketedReyataz
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedabatacept
Graft Versus Host Disease (GVHD)
Marketedadagrasib
Non-Small Cell Lung Cancer
GTPase KRas
Marketedapixaban ODT
Venous Thromboembolism
Marketedbelatacept
Kidney Transplant Rejection
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- ‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal everIf AstraZeneca and Bristol Myers Squibb were to successfully become one company, analysts say it could reset the current deal environment, which has picked up greatly in the first half of the year.biospace · 10d ago
- Neoadjuvant T-DXd Followed by THP Improves RCB in HER2+ Breast CancerTreatment with neoadjuvant T-DXd followed by THP resulted in lower RCB vs ddAC-THP in patients with high-risk, HER2-positive early-stage breast cancer.onclive · 3mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that